Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
–News Direct– Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended
December 24, 2024
–News Direct– Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended
–News Direct– As the weather warms up, motorcycles become increasingly popular modes of transportation. Recently, President at Cycle Gear, Stevan
–News Direct– Empire Metals Ltd (AIM:EEE) managing director Shaun Bunn takes Proactive's Stephen Gunnion through key updates and strategic decisions
–News Direct– Digbee Limited founder and CEO Jamie Strauss and Asante Gold's executive vice president and country director Frederick Attakumah
–News Direct– Ashkenazy Acquisition Corporation, a private real estate investment firm owned by Ben Ashkenazy, is proud to announce that
–News Direct– Global travel technology company, OYOs US operations today announced plans to significantly expand its footprint in the United
–News Direct– Atrato Capital chief investment officer Steven Noble joins Proactive's Stephen Gunnion with news that Supermarket Income REIT PLC
–News Direct– Ondo InsurTech PLC (LSE:ONDO) chief executive Craig Foster joins Proactive's Stephen Gunnion with an update on the deployment
–News Direct– One Media iP Group PLC CEO Michael Infante takes Proactive's Stephen Gunnion through the company's 2023 financial performance,
–News Direct– Poolbeg Pharma PLC CEO Jeremy Skillington and Tim Cot CEO of Silk Road Therapeutics join Proactive's Stephen Gunnion